David Rickey, Director at CYTORI THERAPEUTICS, INC. (CYTX), bought 2,000 shares at $2.62 ($5K) on 2013-09-10, disclosed to the SEC on 2013-09-11.
Open-market purchase of $5k CYTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.62 | 1,000 | $3K | 50.8% |
| 2 | $2.54 | 1,000 | $3K | 49.2% |
| Total | $2.58 avg | 2,000 | $5K | 100% |
| Filing → |
| CYTX | BUY | 2015-08-31 | $17K | — | Filing → |
| CYTX | BUY | 2015-08-28 | $23K | — | Filing → |
| CYTX | BUY | 2015-08-24 | $19K | — | Filing → |